載入...
Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
Recent availability of immune checkpoint inhibitors has facilitated research involving programmed cell death protein 1 (PD-1) and its ligand, programmed death-ligand 1 (PD-L1). However, the incidence and clinical implication of PD-1 and PD-L1 expression in prostate cancer remain poorly understood. T...
Na minha lista:
| 發表在: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer Health
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6756626/ https://ncbi.nlm.nih.gov/pubmed/31567999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017257 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|